USD 2.6
(-5.8%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 84.84 Million USD | 21.42% |
2022 | 66.52 Million USD | 37.35% |
2021 | 48.43 Million USD | 40.56% |
2020 | 34.45 Million USD | 9.25% |
2019 | 31.54 Million USD | 35.65% |
2018 | 23.25 Million USD | 6.54% |
2017 | 21.82 Million USD | 59.47% |
2016 | 13.68 Million USD | 51.73% |
2015 | 9.01 Million USD | 20.54% |
2014 | 7.48 Million USD | 10.02% |
2013 | 6.8 Million USD | 9.84% |
2012 | 6.19 Million USD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 19.84 Million USD | -5.99% |
2024 Q1 | 21.11 Million USD | 0.03% |
2023 Q2 | 20.74 Million USD | -0.06% |
2023 Q3 | 21.16 Million USD | 2.04% |
2023 Q1 | 20.75 Million USD | 17.74% |
2023 Q4 | 21.1 Million USD | -0.27% |
2023 FY | 80.77 Million USD | 21.42% |
2022 Q4 | 17.62 Million USD | 3.78% |
2022 Q3 | 16.98 Million USD | -1.39% |
2022 Q2 | 17.22 Million USD | 17.32% |
2022 FY | 66.52 Million USD | 37.35% |
2022 Q1 | 14.68 Million USD | 5.78% |
2021 Q4 | 13.88 Million USD | 19.27% |
2021 FY | 48.43 Million USD | 40.56% |
2021 Q2 | 10.74 Million USD | -11.78% |
2021 Q3 | 11.63 Million USD | 8.36% |
2021 Q1 | 12.17 Million USD | 21.89% |
2020 FY | 34.45 Million USD | 9.25% |
2020 Q3 | 8.87 Million USD | 17.82% |
2020 Q4 | 9.98 Million USD | 12.61% |
2020 Q2 | 7.52 Million USD | -6.72% |
2020 Q1 | 8.07 Million USD | 5.64% |
2019 Q4 | 7.64 Million USD | 0.18% |
2019 FY | 31.54 Million USD | 35.65% |
2019 Q3 | 7.62 Million USD | -6.36% |
2019 Q2 | 8.14 Million USD | 0.0% |
2019 Q1 | 8.14 Million USD | 29.38% |
2018 Q4 | 6.29 Million USD | 0.0% |
2018 FY | 23.25 Million USD | 6.54% |
2018 Q2 | 5.33 Million USD | 0.0% |
2018 Q3 | 6.29 Million USD | 18.09% |
2018 Q1 | 5.33 Million USD | -13.16% |
2017 Q1 | 4.77 Million USD | 21.86% |
2017 Q2 | 4.77 Million USD | 0.0% |
2017 Q4 | 6.13 Million USD | 0.0% |
2017 Q3 | 6.13 Million USD | 28.6% |
2017 FY | 21.82 Million USD | 59.47% |
2016 Q1 | 2.91 Million USD | 24.79% |
2016 FY | 13.68 Million USD | 51.73% |
2016 Q4 | 3.91 Million USD | 0.0% |
2016 Q3 | 3.91 Million USD | 34.26% |
2016 Q2 | 2.91 Million USD | 0.0% |
2015 Q3 | 2.33 Million USD | 8.16% |
2015 Q2 | 2.16 Million USD | 0.0% |
2015 Q1 | 2.16 Million USD | 8.05% |
2015 FY | 9.01 Million USD | 20.54% |
2015 Q4 | 2.33 Million USD | 0.0% |
2014 FY | 7.48 Million USD | 10.02% |
2014 Q4 | 2 Million USD | 0.0% |
2014 Q1 | 1.74 Million USD | 0.0% |
2014 Q2 | 1.74 Million USD | 0.0% |
2014 Q3 | 2 Million USD | 14.93% |
2013 FY | 6.8 Million USD | 9.84% |
2012 FY | 6.19 Million USD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Acutus Medical, Inc. | 11.22 Million USD | -655.925% |
Cerus Corporation | 143.15 Million USD | 40.732% |
OrthoPediatrics Corp. | 137.01 Million USD | 38.078% |
PetVivo Holdings, Inc. | 11.36 Million USD | -646.818% |
Talis Biomedical Corporation | 67.18 Million USD | -26.284% |
Vivos Therapeutics, Inc. | 24.94 Million USD | -240.115% |
Inogen, Inc. | 236.08 Million USD | 64.062% |
Spectral AI, Inc. | 20.86 Million USD | -306.657% |
Nano-X Imaging Ltd. | 55.99 Million USD | -51.517% |
CVRx, Inc. | 76.14 Million USD | -11.43% |
DIH Holding US, Inc. Warrants | 3.52 Million USD | -2304.906% |
Helius Medical Technologies, Inc. | 12.48 Million USD | -579.358% |
Orthofix Medical Inc. | 667.42 Million USD | 87.288% |
Venus Concept Inc. | 80.47 Million USD | -5.429% |
Accelerate Diagnostics, Inc. | 56.57 Million USD | -49.961% |
Bioventus Inc. | 409.91 Million USD | 79.302% |
BrainsWay Ltd. | 28.01 Million USD | -202.823% |
Envoy Medical, Inc. | 17.89 Million USD | -374.047% |
electroCore, Inc. | 32.03 Million USD | -164.884% |
IceCure Medical Ltd | 16.87 Million USD | -402.755% |
Lucid Diagnostics Inc. | 42.43 Million USD | -99.955% |
Monogram Orthopaedics, Inc. | 17.63 Million USD | -381.171% |
NeuroOne Medical Technologies Corporation | 12.41 Million USD | -583.585% |
Nexalin Technology, Inc. | 5.78 Million USD | -1367.562% |
PAVmed Inc | 64.82 Million USD | -30.879% |
Rapid Micro Biosystems, Inc. | 51.07 Million USD | -66.109% |
RxSight, Inc. | 103.85 Million USD | 18.3% |
Sight Sciences, Inc. | 126.44 Million USD | 32.902% |
SI-BONE, Inc. | 156.35 Million USD | 45.734% |
TELA Bio, Inc. | 84.18 Million USD | -0.782% |
TriSalus Life Sciences, Inc. | 70.05 Million USD | -21.11% |
Treace Medical Concepts, Inc. | 203.36 Million USD | 58.279% |
LivaNova PLC | 843.54 Million USD | 89.942% |
908 Devices Inc. | 68.08 Million USD | -24.625% |
Alphatec Holdings, Inc. | 483.59 Million USD | 82.455% |
Nemaura Medical Inc. | 7.13 Million USD | -1088.505% |
NeuroPace, Inc. | 75.29 Million USD | -12.682% |
LENSAR, Inc. | 33.33 Million USD | -154.515% |
Apyx Medical Corporation | 51.01 Million USD | -66.304% |
Cutera, Inc. | 197.72 Million USD | 57.089% |
STRATA Skin Sciences, Inc. | 24.78 Million USD | -242.379% |
BioSig Technologies, Inc. | 28.53 Million USD | -197.389% |
Anika Therapeutics, Inc. | 191.47 Million USD | 55.689% |
ClearPoint Neuro, Inc. | 36.06 Million USD | -135.288% |
Integra LifeSciences Holdings Corporation | 836.39 Million USD | 89.856% |
Axonics, Inc. | 270.2 Million USD | 68.599% |
Outset Medical, Inc. | 198.77 Million USD | 57.315% |
IRIDEX Corporation | 31.81 Million USD | -166.691% |
PROCEPT BioRobotics Corporation | 180.21 Million USD | 52.921% |
IRadimed Corporation | 30.12 Million USD | -181.664% |
Tivic Health Systems, Inc. | 8.53 Million USD | -894.433% |
INVO Bioscience, Inc. | 7.85 Million USD | -980.375% |
Telesis Bio, Inc. | 63.48 Million USD | -33.637% |
Viemed Healthcare, Inc. | 98.45 Million USD | 13.822% |
Varex Imaging Corporation | 224.8 Million USD | 62.258% |
Quipt Home Medical Corp. | 148.66 Million USD | 42.93% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -623.748% |
Pulmonx Corporation | 112.68 Million USD | 24.707% |
Dynatronics Corporation | 9.9 Million USD | -756.326% |
Modular Medical, Inc. | 17.52 Million USD | -384.026% |
ReShape Lifesciences Inc. | 20.18 Million USD | -320.295% |
Semler Scientific, Inc. | 38.94 Million USD | -117.864% |
InMode Ltd. | 215.68 Million USD | 60.662% |
Bruker Corporation | 1.07 Billion USD | 92.118% |
Cytosorbents Corporation | 48.33 Million USD | -75.529% |
DexCom, Inc. | 1.69 Billion USD | 94.983% |
Align Technology, Inc. | 2.07 Billion USD | 95.915% |
Viveve Medical, Inc. | 22.17 Million USD | -282.65% |
ZimVie Inc. | 275.12 Million USD | 69.161% |
Movano Inc. | 29.69 Million USD | -185.77% |
Cytek Biosciences, Inc. | 137.27 Million USD | 38.192% |
Nexalin Technology, Inc. | 5.78 Million USD | -1367.562% |
DIH Holdings US, Inc. Class A Common Stock | 3.52 Million USD | -2304.906% |
Tandem Diabetes Care, Inc. | 600.92 Million USD | 85.881% |
Profound Medical Corp. | 33.6 Million USD | -152.491% |
Insulet Corporation | 939.9 Million USD | 90.973% |
enVVeno Medical Corporation | 25.23 Million USD | -236.18% |
Surmodics, Inc. | 98.69 Million USD | 14.035% |
iCAD, Inc. | 22.22 Million USD | -281.755% |
Nuwellis, Inc. | 22.61 Million USD | -275.205% |
Biotricity, Inc. | 17.18 Million USD | -393.728% |
iRhythm Technologies, Inc. | 445.88 Million USD | 80.972% |
Aethlon Medical, Inc. | 12.27 Million USD | -591.06% |
InspireMD, Inc. | 22.95 Million USD | -269.695% |
PAVmed Inc. | 64.82 Million USD | -30.879% |
BIOLASE, Inc. | 34.66 Million USD | -144.785% |
Beyond Air, Inc. | 61.7 Million USD | -37.512% |
FONAR Corporation | 28.6 Million USD | -196.612% |
AxoGen, Inc. | 149.33 Million USD | 43.185% |
Vivani Medical, Inc. | 26.96 Million USD | -214.649% |
Tactile Systems Technology, Inc. | 177.09 Million USD | 52.09% |
Inari Medical, Inc. | 448.59 Million USD | 81.087% |
UFP Technologies, Inc. | 58.08 Million USD | -46.06% |
QT Imaging Holdings, Inc. | 4.92 Million USD | -1621.832% |
Heart Test Laboratories, Inc. | 6.31 Million USD | -1242.848% |
Tenon Medical, Inc. | 16.96 Million USD | -400.029% |
Autonomix Medical, Inc. Common Stock | 7.39 Million USD | -1047.64% |
Co-Diagnostics, Inc. | 44.1 Million USD | -92.38% |
AdaptHealth Corp. | 1.07 Billion USD | 92.129% |
Sintx Technologies, Inc. | 15.2 Million USD | -458.154% |
NanoVibronix, Inc. | 4.97 Million USD | -1606.113% |
Quanterix Corporation | 118.1 Million USD | 28.158% |
Inspira Technologies Oxy B.H.N. Ltd. | 11.72 Million USD | -623.748% |
Sensus Healthcare, Inc. | 14.44 Million USD | -487.488% |
Pacific Biosciences of California, Inc. | 392.66 Million USD | 78.393% |
TransMedics Group, Inc. | 182.82 Million USD | 53.591% |
ReWalk Robotics Ltd. | 28.06 Million USD | -202.316% |
NeuroMetrix, Inc. | 11.09 Million USD | -664.443% |
Hyperfine, Inc. | 52.87 Million USD | -60.472% |
Establishment Labs Holdings Inc. | 172 Million USD | 50.672% |
Biomerica, Inc. | 6.97 Million USD | -1115.893% |
Bone Biologics Corporation | 9.42 Million USD | -799.897% |
AVITA Medical, Inc. | 80.77 Million USD | -5.033% |
Bluejay Diagnostics, Inc. | 10.31 Million USD | -722.842% |
Silk Road Medical, Inc | 186.35 Million USD | 54.472% |